FARHAN BHATTI: Open Payments
NPI 1326308057 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,778 in 137 payments from 26 companies in 2025. Trend: 2023 $37,553 · 2024 $15,338 · 2025 $15,778
Speaker / faculty: $12,000Food & beverage: $1,726Consulting: $1,688Travel & lodging: $251Education: $114
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $14,090 |
| Otsuka America Pharmaceutical, Inc. | 29 | $327 |
| Teva Pharmaceuticals USA, Inc. | 9 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $199 |
| Alkermes, Inc. | 6 | $152 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| PFIZER INC. | 4 | $68 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| Janssen Pharmaceuticals, Inc | 3 | $68 |
| Abbott Laboratories | 3 | $59 |
Products named: VRAYLAR, UBRELVY, CAPLYTA, REXULTI, ABILIFY MAINTENA, ARISTADA, COBENFY, INGREZZA.
Industry payments across MI — which companies pay providers there.
